Findings presented at the European Respiratory Society Congress 2026 suggest semaglutide may offer respiratory benefits beyond its approved diabetes and obesity indications.
|Articles|July 7, 2022
Daily OTC Pearl: After Bite
Author(s)Saro Arakelians, PharmD
After Bite is indicated for relieving itch from bug bites and other mild irritations.
Advertisement
OTC/Lifestyle Pearl of the Day: After Bite
Indication: After Bite is indicated for relieving itch from bug bites and other mild irritations.
Insight:
- Comes in a portable pen.
- Available in advanced formula and advanced formula with baking soda.
- Directions: Adults and children 2 years and older apply directly on bite or sting, rub gently and re-apply as needed. For children under 2 years of age, consult a physician.
- For external use only.
- Do not use on deep puncture wounds serious burns.
- Do not get into eyes.
- Keep out of reach of children. If swallowed, get medical help or contact a poison control center right away. If in eyes, flush with water for 15 minutes and call a physician.
Source:
Advertisement
Related to this article
Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
The data helps pharmaicts predict who will react strongly to mRNA vaccines—giving them a science-backed talking point during respiratory season.
CDC-recommended adult vaccination programs for pneumococcal disease, RSV, influenza, and COVID-19 prevent over 182,000 deaths and generate up to $12 in societal value for every $1 spent.
This article discusses a recent publication examining pharmacy access across Minnesota and explores the complex factors contributing to threatened community health access across the US.
Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
New European Respiratory Society (ERS) update makes sotatercept a strong add-on recommendation, opening a fourth pathway for pharmacists to manage.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
2
Semaglutide Linked to Up to 40% Fewer Asthma Attacks, Real-World Data Show
3
FDA Approves Levacetylleucine to Treat Ataxia in Adult, Pediatric Patients With A-T
4
Baseline Interferon Activity in Monocytes Predicts mRNA Vaccine Adverse Effects, Study Finds
5